As an essential hub in the ferroptosis regulatory network, FSP1 leverages its unique CoQ10 and VK reductase activities to shield cancer cells from oxidative and ferroptotic damage, thereby fueling tumor progression and treatment resistance across diverse malignancies. Here, AIFM2 is linked to cancer.